Alteration of electroencephalogram and monoamine concentrations in rat brain following ibogaine treatment. (Q48427798)

11 February 2018

title

Alteration of electroencephalogram and monoamine concentrations in rat brain following ibogaine treatment. (English)

1 reference

11 February 2018

1 reference

Binienda Z

1

1 reference

11 February 2018

Beaudoin MA

2

1 reference

11 February 2018

Thorn BT

3

1 reference

11 February 2018

Prapurna DR

4

1 reference

11 February 2018

Johnson JR

5

1 reference

11 February 2018

Fogle CM

6

1 reference

11 February 2018

Slikker W Jr

7

1 reference

11 February 2018

Ali SF

8

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

11 February 2018

Annals of the New York Academy of Sciences

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 February 2018

volume

844

1 reference

11 February 2018

page(s)

265-273

1 reference

11 February 2018

Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Inhibitory effects of ibogaine on cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Ibogaine-like effects of noribogaine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Ibogaine neurotoxicity: a re-evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum. Neurohistological biomarkers of Purkinje cell loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

The effect of ibogaine on kappa-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6By mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB08241.X

10.1111/J.1749-6632.1998.TB08241.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9668684

1 reference

11 February 2018